Pharmaceutical

Image

Global Leptospirosis Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • May 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Leptospirosis Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 447.80 Million
Diagram Market Size (Forecast Year) USD 708.36 Million
Diagram CAGR %

Global Leptospirosis Market, By Treatment (Medication, Others), Diagnosis (Complete Blood Count (CBC) Creatine Kinase, Liver Enzymes, Urinalysis, Blood Cultures), Symptoms (Headache, Muscle Ache, Jaundice, Vomiting, Diarrhea, Skin Rash, Others), Route of Administration (Oral, Parenteral, Others), Dosage Form (Tablets, Capsules, Injections, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029

Market Analysis and Size

In recent years, the leptospirosis market is anticipated to grow rapidly during the forecast period. Leptospirosis is the most frequent zoonosis in the world, and it's linked to filthy environments and agricultural occupations that require contact with animals or water. Adventure travel and mud run sports or races involving fresh water or dirt exposure are increasing the risk for humans. Humans are not often thought of as reservoirs, yet they can shed leptospires on a regular basis and operate as reservoirs in locations where endemicity is high and waste sanitation is inadequate. In the United States, 100 to 150 infections are reported each year, with the majority occurring in the late summer and early fall. Many infections are undetected because moderate leptospirosis usually causes nonspecific, flu-like symptoms that go away on their own.

Data Bridge Market Research analyses that the leptospirosis market was valued at USD 447.8 million in 2021 and is expected to reach USD 708.36 million by 2029, registering a CAGR of 5.90% during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Leptospirosis is a bacterial infection transferred by the Leptospira bacteria. The bacterium can be found in the kidneys of numerous mammals. It spreads to humans through breaks in the skin, such as cuts, open wounds, or dry areas, when contaminated animal poo material is present in the soil and water. It spreads through the nose, mouth, and genitals, but it's difficult to contract it from another person, however it can be transmitted through personal contact or nursing.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Treatment (Medication, Others), Diagnosis (Complete Blood Count (CBC) Creatine Kinase, Liver Enzymes, Urinalysis, Blood Cultures), Symptoms (Headache, Muscle Ache, Jaundice, Vomiting, Diarrhea, Skin Rash, Others), Route of Administration (Oral, Parenteral, Others), Dosage Form (Tablets, Capsules, Injections, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (US), Merck & Co., Inc. (US), Allergan (Ireland), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Cipla Inc. (US), Abbott (US), AbbVie Inc. (US), Merck KGaA (Germany), Sun Pharmaceutical Industries Ltd. (India), Aurobindo Pharma (India), Lupin (India), Fresenius Kabi AG (Germany), Tolmar Pharmaceuticals, Inc. (US), Almirall, S.A (Spain), Baxter (US), Hikma Pharmaceuticals PLC (UK)

Market Opportunities

  • Increase in the number of emerging markets
  • Increase in the number of research and development activities
  • Rising investment for the development of advanced technologies
  • Surging drug approvals and launches

Leptospirosis Market Dynamics

Drivers

  • Increasing prevalence of animal-related bacterial infections globally

The rising prevalence of animal-related bacterial infections globally is estimated to enhance the leptospirosis market's growth rate. Rats, skunks, opossums, foxes, and raccoons are among the animals that can spread the disease to humans. Open wounds, eyes, and mucous membranes are all areas where germs can enter the body.

  • Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of leptospirosis market is the rising healthcare expenditure which helps in improving its infrastructure. Also, various government organizations aims to improve the healthcare infrastructure by increasing funding and this will further influence the market dynamics.

  • Growing awareness about prevention and possible complications

The surging awareness about prevention and possible complications among people is estimated to enhance the market's expansion during the forecast period of 2022-2029. Jarisch-Herxheimer reaction when penicillin is given, severe bleeding and meningitis are the possible complications associated with this disease.

Furthermore, rising initiatives by public and private organizations to spread awareness will expand the leptospirosis market. Additionally, changing lifestyle of people and rising geriatric population will result in the expansion of leptospirosis market.

Opportunities

  • Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the leptospirosis market growth. Along with this, rising drug approvals and launches will further propel the market’s growth rate. The advent of new as well as more efficient diabetic treatment and monitoring products is estimated to boost the market’s growth rate in future. 

Moreover, rising investment for the development of advanced technologies and increase in the number of emerging markets will further provide beneficial opportunities for the leptospirosis market growth during the forecast period.

Restraints/Challenges

On the other hand, high cost high cost associated with the treatment will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the leptospirosis market. Additionally, the scarcity of clinical suspicion and barriers to diagnostic capacity and lack of awareness among people will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This leptospirosis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the leptospirosis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Leptospirosis is more common in tropical climates. As per the World Health Organization (WHO) it affects approximately 10 or more persons per 100,000 each year. It affects between 0.1 and 1 per 100,000 people in temperate climates. It can affect 100 or more persons per 100,000 in an outbreak.

Leptospirosis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Leptospirosis Market

Over the projected period, the leptospirosis market was expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in a number of nations had imposed nationwide lockdowns in order to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world were having difficulty continuing their supply chain activities. The leptospirosis market has also been hampered by the supply chain slowness.

Global Leptospirosis Market Scope

The leptospirosis market is segmented on the basis of treatment, diagnosis, symptoms, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Medication

Antibiotics

  • Ampicillin
  • Azithromycin
  • Ceftriaxone
  • Doxycycline
  • Penicillin
  • Others

Others

Diagnosis

  • Complete Blood Count (CBC)
  • Creatine Kinase
  • Liver Enzymes
  • Urinalysis
  • Blood Cultures

Symptoms

  • Headache
  • Muscle Ache
  • Jaundice
  • Vomiting
  • Diarrhea
  • Skin Rash
  • Others

Dosage form

  • Tablets
  • Capsules
  • Injections
  • Others

Route of Administration

  • Oral
  • Parenteral
  • Others

End-Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

Leptospirosis Market Regional Analysis/Insights

The leptospirosis market is analysed and market size insights and trends are provided by country, treatment, diagnosis symptoms, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Leptospirosis market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the leptospirosis market because of the growing number of research and development activities and rising healthcare expenditure will further propel the market’s growth rate in this region. Additionally, growing adoption of advanced technology will further influence the market’s growth rate in this region

Asia-Pacific are expected to grow during the forecast period due to surging number of generic manufacturers and increasing animal husbandry and poultry in this region. Also, development of healthcare infrastructure will further propel the market’s growth rate in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Leptospirosis Market Share Analysis

The Leptospirosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to leptospirosis market.

Some of the major players operating in the leptospirosis market are:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (US)
  • Teva Pharmaceutical Industries Ltd. (Ireland)
  • Sanofi (France)
  • Pfizer Inc. (US)
  • GlaxoSmithKline plc (UK)
  • Novartis AG (Switzerland)
  • Bayer AG (Germany)
  • Eli Lilly and Company (US)
  • Merck & Co., Inc. (US)
  • Allergan (Ireland)
  • AstraZeneca (UK)
  • AbbVie Inc. (US)
  • Johnson & Johnson Private Limited (US)
  • Cipla Inc. (US)  
  • Abbott (US)
  • Merck KGaA (Germany)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Aurobindo Pharma (India)
  • Lupin (India)
  • Hikma Pharmaceuticals PLC (UK)
  • Fresenius Kabi AG (Germany)
  • Tolmar Pharmaceuticals, Inc. (US)
  • Almirall, S.A (Spain)
  • Baxter (US)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The market value for Leptospirosis Market is expected USD 708.36 million by 2029.
The Leptospirosis Market is to grow at a CAGR of 5.90% during the forecast period of 2022 to 2029
The major players operating in the Leptospirosis Market are GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Bayer AG (Germany), Eli Lilly and Company (US), Merck & Co., Inc. (US), Allergan (Ireland), AstraZeneca (UK), Johnson & Johnson Private Limited (US), Cipla Inc. (US), etc.
The major countries covered in the Leptospirosis Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, etc.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials